Literature DB >> 4825951

Gallbladder visualization following hepatic arteriography for hemangioma.

A A Frey, K Ranniger, F J Roth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4825951     DOI: 10.1007/bf01255612

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


× No keyword cloud information.
  13 in total

1.  Opacification of the small bowel with intravenously administered contrast medium.

Authors:  E SALZMAN; J T McCLINTOCK
Journal:  Radiology       Date:  1963-05       Impact factor: 11.105

2.  [On heterotopic excretion of urografin].

Authors:  J RETHELYI
Journal:  Fortschr Geb Rontgenstr Nuklearmed       Date:  1962-09

Review 3.  Urographic contrast media in uremia. Physiology and pharmacology.

Authors:  L B Talner
Journal:  Radiol Clin North Am       Date:  1972-12       Impact factor: 2.303

4.  Angiographic features of cavernous hemangioma of liver.

Authors:  R M Abrams; E R Beranbaum; J S Santos; J Lipson
Journal:  Radiology       Date:  1969-02       Impact factor: 11.105

5.  The role of the Y and Z hepatic proteins in the excretion of radiographic contrast materials.

Authors:  J Sokoloff; R N Berk; J H Lang; E C Lasser
Journal:  Radiology       Date:  1973-03       Impact factor: 11.105

6.  Opacification of the gallbladder by urographic contrast media. Reflection of an alternate excretory pathway.

Authors:  T E Shea; R C Pfister
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1969-12

7.  Gallbladder seen on excretory urography: a case report.

Authors:  R Arkless
Journal:  J Urol       Date:  1969-12       Impact factor: 7.450

8.  Angiography in liver hemangioma.

Authors:  E Pantoja
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1968-12

9.  Gallbladder visualization following the injection of diatrizoate.

Authors:  H D Segall
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1969-09

10.  Extra-renal excretion of contrast material a possible indicator of renal damage.

Authors:  J Jancu; G Shapiro
Journal:  Clin Radiol       Date:  1971-04       Impact factor: 2.350

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.